Abstract

The complex challenges posed by mental illness, which accounts for roughly one third of adult disability worldwide, are not adequately addressed by both the prevalent mental health care model and the treatments that are currently in use. As a result of these circumstances, fundamental shifts in the mental health care paradigm and practices are required. These shifts include raising the requirements for clinician training, developing novel approaches to research, and rethinking the ways in which mental health care is currently provided. Kaiser Permanente (KP) is strategically positioned to make significant contributions that will shape the future of mental health care on a national and international scale due to its commitment to research and innovation as well as its dominant position in the US health care market

Keywords: Mental health, Psychotherapy, Nutraceuticals, Psychotropics